|Articles|September 25, 2013

Multi-Faceted Infection Control Program Decreases Clinical Impact of CVC-ABSIs

Outside of intensive care units (ICUs), central venous catheter-associated bloodstream infections (CVC-ABSIs)' epidemiology and the results of strategies for their prevention are not well known. The aim of the study by García-Rodríguez, et al. (2013) was to investigate the epidemiology and the impact of a multifaceted bundle approach in controlling CVC-ABSIs outside of the ICU.
 
From 1991 the researchers performed prevalence studies of device and parenteral nutrition use, and prospective surveillance of all episodes of CVC-ABSIs in a 350-bed teaching hospital. CVC-ABSIs incidence/1,000 inpatient-days was calculated. An estimated CVC-ABSIs incidence/1,000 catheter-days was calculated based on the prevalence rates of catheter use and the total number of inpatient-days in each year.

In November 2008, an education program was instituted for care of catheter lines -- reinforcing instructions in aseptic insertion technique, after care and handwashing -- in order to assess the adherence to these measures the quantity of alcohol-based hand-rub consumption/1,000 patient-days was quoted in liters.

In January 2009, a checklist intervention for CVC insertion in ICU was started: hand hygiene, using full barrier precautions, cleaning the skin with alcoholic chlorhexidine, avoiding femoral access and removing unnecessary catheters. Compliance with the central line insertion checklist was measured by real-time audits and was achieved in 80 percent of cases.

Prevalence of use of CVC and parenteral nutrition was similar throughout the study. The researchers followed up on 309 CVC-ABSIs cases. Estimated CVC-ABSIs rate progressively increased to 15.1/1,000 catheter-days in 2008 (0.36/1,000 inpatient-days). After the intervention, the alcohol-based hand-rub consumption increased slightly and estimated CVC-ABSIs rate fell to 10.1 /1,000 catheter-days in last three years (0.19/1,000 inpatient-days), showing a 32.9 percent decrease. The infection rates achieved were lower in internal medicine wards: decreased from 14.1/1,000 catheter-days (0.17/patient-days) in 2008 to 5.2/1,000 catheter-days (0.05/1,000 inpatient-days) in last three years, showing a 63.1 percent decrease. In 2009, the estimated CVC-ABSIs incidence rate was significantly lower in the Internal Medicine ward compared to the Surgery ward: rate ratio (RR) = 0.14, 95%CI: 0.03-0.60), and within the Internal Medicine ward, the estimated CVC-ABSIs incidence rate was significantly lower in 2009 compared to 2008 (RR = 0.20, 95% CI: 0.04-0.91).
 
The researchers conclude that the rate of CVC-ABSIs increased outside of the ICU, and the implementation of a multifaceted infection control program decreased their clinical impact. Their research was published in BMC Infectious Diseases.

Reference: García-Rodríguez JF, et al. Epidemiology and impact of a multifaceted approach in controlling central venous catheter-associated blood stream infections outside the intensive care unit. BMC Infectious Diseases 2013, 13:445 doi:10.1186/1471-2334-13-445

 


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.